Skip to main content
SpringerLink
Log in
Book cover

Gastrointestinal Oncology pp 67–100Cite as

Esophageal Cancer

  • Chapter
  • First Online:

  • 1729 Accesses

Abstract

Esophageal cancer has an increasing incidence in countries with a Western life style. This phenomenon must be attributed to the increasing number of adenocarcinoma of the distal esophagus that is associated with gastroesophageal reflux and obesity.

With regard to risk factors by location of the tumor and with regard to prognosis, squamous cell cancer and adenocarcinoma must be seen as two distinct tumor entities.

Treatment for esophageal cancer is stage-dependent. When distant metastases have been excluded, patients should undergo a sophisticated staging, in order to fix the clinical stage as accurate as possible. In mucosa cancer, endoscopic mucosa resection is associated with a very favorable outcome and can now be regarded as a standard of care. Limited resection (Merendino procedure) and subtotal esophagectomy in selected cases are alternative treatment options.

Radical transthoracic esophagectomy is the standard of care for treating the majority of patients presenting with locally advanced tumors. In tumors that penetrate the whole esophageal wall and in presumably nodal positive tumors, neoadjuvant treatment has become a standard of care. While in adenocarcinoma there are positive data for neoadjuvant chemotherapy alone, radiation should be added in squamous cell cancer and seems to be at least as effective as chemotherapy alone in adenocarcinoma. Radiation adds anti-tumor activity but also toxicity and leads to an increased postoperative morbidity. In patients presenting with metastatic disease, palliative treatment is indicated. This usually comprises systemic platinum-chemotherapy. Treatment for advanced adenocarcinoma of the esophagus follows the same rules as chemotherapy for advanced gastric adenocarcinoma. Additionally, endoscopic treatment for alleviating symptoms from local tumor growth is often required.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abou-Jawde JM, Mekhail T, Adelstein DJ et al (2005) Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 128:250–256

    PubMed  Google Scholar 

  • Ahsan H, Neugut AI (1998) Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Intern Med 128(2):114

    CAS  PubMed  Google Scholar 

  • Allum WH, Stenning SP, Bancewicz J et al (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062–5067

    PubMed  Google Scholar 

  • Ando N, Iizuka T, Kakegawa T et al (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114:205–259

    CAS  PubMed  Google Scholar 

  • Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study – JCOG9204. J Clin Oncol 21:4592–4596

    PubMed  Google Scholar 

  • Arnott SJ, Duncan W, Gignoux M et al (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev:CD001799

    Google Scholar 

  • Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85:840–844

    CAS  PubMed  Google Scholar 

  • Bartels H, Stein HJ, Siewert JR (2000) Risk analysis in esophageal surgery. Recent Results Cancer Res 155:89–96

    CAS  PubMed  Google Scholar 

  • Bedenne L, Michel P, Bouché O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168

    CAS  PubMed  Google Scholar 

  • Berger AC, Farma J, Scott WJ, Freedman G et al (2005) Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23:4330–4337

    PubMed  Google Scholar 

  • Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137

    PubMed  Google Scholar 

  • Birkmeyer JD, Sun Y, Wong SL et al (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245:777–783

    PubMed  Google Scholar 

  • Blazeby JM, Sanford E, Falk SJ et al (2004) Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 103:1791–1798

    Google Scholar 

  • Bleiberg H, Conroy T, Paillot B et al (1997) Randomized phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced oesophageal cancer. Eur J Cancer 33:1216–1220

    CAS  PubMed  Google Scholar 

  • Bollschweiler E, Schröder W, Hölscher AH et al (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87:1106–1110

    CAS  PubMed  Google Scholar 

  • Bollschweiler E, Baldus SE, Schröder W et al (2006) High rate of lymph node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38:144–151

    Google Scholar 

  • Bollschweiler E, Metzger R, Drebber U et al (2009) Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 20:231–238

    CAS  PubMed  Google Scholar 

  • Bonnetain F, Bouché O, Michel P et al (2006) A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17:827–834

    CAS  PubMed  Google Scholar 

  • Brenner B, Ilson DH, Minsky BD et al (2004) Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuos-infusion paclitaxel with cisplatin and concurrent radiation therapy. J Clin Oncol 22:45–52

    CAS  PubMed  Google Scholar 

  • Brücher BL, Becker K, Lordick F et al (2006) The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 106:2119–2127

    PubMed  Google Scholar 

  • Brücher BL, Swisher SG, Königsrainer A et al (2009) Response to preoperative therapy in upper gastrointestinal cancers. Ann Surg Oncol 16:878–886

    PubMed  Google Scholar 

  • Burian M, Stein HJ, Sendler A et al (2004) Sentinel lymph node mapping in gastric and esophageal carcinomas. Chirurg 75:756–760

    CAS  PubMed  Google Scholar 

  • Burmeister B, Smithers M, Gebski V et al (2005) A randomised phase III study comparing surgery alone with chemoradiation therapy followed by surgery for resectable carcinoma of the oesophagus: an intergroup study of the Trans-Tasman Radiation Oncology Group (TROG) and the Australasian Gastro-Intestinal Trials Group (AGITG). Lancet Oncol 6:659–668

    PubMed  Google Scholar 

  • Chau I, Norman AR, Cunningham D et al (2009) The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma – individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol 20:885–891

    CAS  PubMed  Google Scholar 

  • Conroy T, Etienne PL, Adenis A et al (2002) Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival. Ann Oncol 13:721–729

    CAS  PubMed  Google Scholar 

  • Crehange G, Maingon P, Peignaux K et al (2007) Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 25:4895–4901

    CAS  PubMed  Google Scholar 

  • Das D, Chilton AP, Jankowski JA (2009) Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res 181:161–169

    CAS  PubMed  Google Scholar 

  • Dhillon PK, Farrow DC, Vaughan TL et al (2001) Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 93:148–152

    CAS  PubMed  Google Scholar 

  • Downey RJ, Akhurst T, Ilson D, Ginsberg R et al (2003) Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21:428–432

    PubMed  Google Scholar 

  • Dragovich T, McCoy S, Fenoglio-Preiser CM et al (2004) Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. J Clin Oncol 24:4922–4927

    Google Scholar 

  • Ell C, May A, Gossner L et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118:670–677

    CAS  PubMed  Google Scholar 

  • Feith M, Stein HJ, Siewert JR (2003) Pattern of lymphatic spread of Barrett’s cancer. World J Surg 27:1052–1057

    PubMed  Google Scholar 

  • Fiorica F, Di Bona D, Schepis F et al (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53:925–930

    CAS  PubMed  Google Scholar 

  • Flamen P, Van Cutsem E, Lerut A, Cambier JP et al (2002) Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 13:361–381

    CAS  PubMed  Google Scholar 

  • Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    CAS  PubMed  Google Scholar 

  • Greer SE, Goodney PP, Sutton JE et al (2005) Neoadjuvant chemoradiation for esophageal carcinoma: a meta-analysis. Surgery 137:172–179

    PubMed  Google Scholar 

  • Grotenhuis BA, Wijnhoven BP, van Marion R et al (2009) The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 138:608–612

    PubMed  Google Scholar 

  • Gutschow C, Schröder W, Wolfgarten E et al (2004) Operation nach Merendino mit Vaguserhaltung beim Frühkarzinom des gastroösophagealen Übergangs. Zentralbl Chir 129:276–281

    CAS  PubMed  Google Scholar 

  • Hao Y, Triadafilopoulos G, Sahbaie P et al (2006) Gene expression profiling reveals stromal genes expressed in common between Barrett’s esophagus and adenocarcinoma. Gastroenterology 131:925–933

    CAS  PubMed  Google Scholar 

  • Hardwick RH, Williams GT (2002) Staging of oesophageal adenocarcinoma. Br J Surg 89:1076–1077

    Google Scholar 

  • He D, Zhang DK, Lam KY et al (1997) Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72:959–964

    CAS  PubMed  Google Scholar 

  • Heidecke CD, Weighardt H, Feith M et al (2002) Neoadjuvant treatment of the esophageal cancer: immunosuppression following combined radiochemotherapy. Surgery 132:495–501

    PubMed  Google Scholar 

  • Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992(326):1593–1598

    Google Scholar 

  • Higuchi K, Koizumi W, Tanabe S et al (2009) Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 3:153–161

    PubMed  Google Scholar 

  • Hofstetter W, Correa AM, Bekele N et al (2007) Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84:365–373

    PubMed  Google Scholar 

  • Hölscher AH, Vallböhmer D (2007) Surgical treatment of esophageal tumors including local ablation. Zentralbl Chir 132:18–36

    Google Scholar 

  • Hölscher AH, Bollschweiler E, Bumm R et al (1995) Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 118:845–855

    PubMed  Google Scholar 

  • Hölscher AH, Schröder W, Bollschweiler E et al (2003) Wie sicher ist die hoch intrathorakale Ösophagogastrostomie? Chirurg 74:726–733

    PubMed  Google Scholar 

  • Hölscher AH, Metzger R, Brabender J et al (2004) High-volume centers – effect of case load on outcome in cancer surgery. Onkologie 27:412–416

    PubMed  Google Scholar 

  • Hölscher AH, Schneider PM, Gutschow C et al (2007) Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Am Surg 245:241–246

    Google Scholar 

  • Hulscher JBF, Van Sandick JW, De Beure AGEM et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669

    PubMed  Google Scholar 

  • Ilson DH, Saltz L, Enzinger P et al (1999) Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 10:3270–3275

    Google Scholar 

  • Ilson DH, Bains M, Kelsen DP et al (2003) Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21:2962–2969

    Google Scholar 

  • Inoue H, Minami H, Kaga M et al (2010) Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma. Gastrointest Endosc Clin N Am 20:25–34

    PubMed  Google Scholar 

  • Javeri H, Arora R, Correa AM et al (2008) Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer 113:1302–1308

    PubMed  Google Scholar 

  • Javeri H, Xiao L, Rohren E et al (2009) The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation the better the survival of patients with gastroesophageal adenocarcinoma. Cancer 115:5184–5192

    PubMed  Google Scholar 

  • Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150

    PubMed  Google Scholar 

  • Kamangar F, Chow WH, Abnet CC et al (2009) Environmental causes of esophageal cancer. Gastroenterol Clin North Am 38:27–57

    PubMed  Google Scholar 

  • Kelly S, Harris KM, Berry E et al (2001) A systematic review of the staging performance of endoscopic ultrasound on gastro-oesophageal carcinoma. Gut 49:534–539

    CAS  PubMed  Google Scholar 

  • Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984

    CAS  PubMed  Google Scholar 

  • Kelsen DP, Winter KA, Gunderson LL et al (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25:3719–3725

    PubMed  Google Scholar 

  • Kesting MR, Schurr C, Robitzky L et al (2009) Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma – value of endoscopic screening: 10-year experience. J Oral Maxillofac Surg 67:1649–1655

    PubMed  Google Scholar 

  • Khushalani NI, Leichman CG, Proulx G et al (2002) Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20:2844–2850

    CAS  PubMed  Google Scholar 

  • Kleinberg L, Gibson MK, Forastiere AA (2007) Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization. Nat Clin Pract Oncol 4:282–294

    CAS  PubMed  Google Scholar 

  • Lagergren J (2005) Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54(suppl 1):i1–i5

    PubMed  Google Scholar 

  • Lagergren JL, Bergstrom R, Lindgren A et al (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831

    CAS  PubMed  Google Scholar 

  • Lagergren P, Avery KN, Hughes R et al (2007a) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 110(3):686–693

    PubMed  Google Scholar 

  • Lagergren P, Fayers P, Conroy T et al (2007b) Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer 43(14):2066–2073

    PubMed  Google Scholar 

  • Launoy G, Milan CH, Faivre J et al (1997) Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer 75:1389–1396

    CAS  PubMed  Google Scholar 

  • Leers JM, Bollschweiler E, Hölscher AH (2005) Refluxanamnese von Patienten mit Adenokarzinom der Speiseröhre. Z Gastroenterol 43:275–280

    CAS  PubMed  Google Scholar 

  • Lightdale CJ (1996) Diagnosis of esophagogastric tumors. Endoscopy 28:22–26

    Google Scholar 

  • Liu L, Hofstetter WL, Rashid A et al (2005) Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive esophageal adenocarcinoma. Am J Surg Pathol 29:1079–1085

    PubMed  Google Scholar 

  • Löfdahl HE, Lu Y, Lagergren J (2008) Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer 99:1506–1510

    PubMed  Google Scholar 

  • Lordick F (2009) Principles of neoadjuvant therapy. Chirurg 80:1000–1005

    CAS  PubMed  Google Scholar 

  • Lordick F, Stein HJ, Peschel C et al (2004) Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 91:540–551

    CAS  PubMed  Google Scholar 

  • Lordick F, Ebert M, Stein HJ (2006) Current treatment approach to locally advanced esophageal cancer: is resection mandatory? Future Oncol 2:717–721

    PubMed  Google Scholar 

  • Lordick F, Ott K, Krause BJ et al (2007) Use of PET to assess early metabolic response and to guide treatment of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805

    PubMed  Google Scholar 

  • Lorenzen S, Duyster J, Lersch C et al (2005) Capecitabine plus docetaxel every three weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. Br J Cancer 92:2129–2133

    CAS  PubMed  Google Scholar 

  • Lorenzen S, Brücher B, Zimmermann F et al (2008) Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer 99:1020–1026

    CAS  PubMed  Google Scholar 

  • Lorenzen S, Schuster T, Porschen R et al (2009) Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 20:1667–1673

    CAS  PubMed  Google Scholar 

  • Malthaner R, Fenlon D (2003) Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 4:CD001556

    Google Scholar 

  • Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359:1727–1733

    Google Scholar 

  • Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63:5–24

    PubMed  Google Scholar 

  • Minsky B, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1151–1153

    Google Scholar 

  • Moodley R, Reddi A, Chetty R et al (2007) Abnormalities of chromosome 17 in oesophageal cancer. J Clin Pathol 60:990–994

    CAS  PubMed  Google Scholar 

  • Natsugoe S, Kaminosono H, Arigami T et al (2009) Upper G.I. cancer: the esophagus and stomach. III. The current status and overview on sentinel node navigation surgery of esophageal cancer. Gan To Kagaku Ryoho 36:1442–1446

    PubMed  Google Scholar 

  • Neumann H, Mönkemüller K, Vieth M et al (2009) Chemoprevention of adenocarcinoma associated with Barrett’s esophagus: potential options. Dig Dis 27:18–23

    PubMed  Google Scholar 

  • Nygaard K, Hagen S, Hansen HS et al (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109

    CAS  PubMed  Google Scholar 

  • Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246:992–1000

    PubMed  Google Scholar 

  • Ott K, Weber WA, Lordick F et al (2006) Metabolic imaging predicts response, survival and recurrence in adenocarcinomas of the esophagogastric junction (AEG) in a prospective trial. J Clin Oncol 24:4692–4698

    PubMed  Google Scholar 

  • Ott K, Bader FG, Lordick F et al (2009a) Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center. Ann Surg Oncol 16:1017–1025

    PubMed  Google Scholar 

  • Ott K, Lordick F, Molls M et al (2009b) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96:258–266

    CAS  PubMed  Google Scholar 

  • Pech O, Ell C (2009a) Endoscopic therapy of Barrett’s esophagus. Curr Opin Gastroenterol 25:405–411

    PubMed  Google Scholar 

  • Pech O, Ell C (2009b) Editorial: resecting or burning: what should we do with the remaining Barrett’s epithelium after successful ER of neoplasia? Am J Gastroenterol 104:2693–2694

    PubMed  Google Scholar 

  • Pech O, May A, Gossner L et al (2007) Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 39:30–35

    CAS  PubMed  Google Scholar 

  • Piert M, Burian M, Meisetschläger G et al (2007) Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 34:1534–1544

    PubMed  Google Scholar 

  • Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 19(97):142–146

    Google Scholar 

  • Qiao YL, Dawsey SM, Kamangar F et al (2009) Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101:507–518

    CAS  PubMed  Google Scholar 

  • Riedel M, Hauck RW, Stein HJ et al (1998) Preoperative bronchoscopic assessment of airway invasion by esophageal cancer: a prospective study. Chest 113:687–695

    CAS  PubMed  Google Scholar 

  • Riedel M, Stein HJ, Mounyam L et al (2001) Extensive sampling improves preoperative bronchcoscopic assessment of airway invasion by supracarinal esophageal cancer. Chest 119:1652–1660

    CAS  PubMed  Google Scholar 

  • Rizk NP, Venkatraman E, Bains MS et al; American Joint Committee on Cancer (2007) American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25:507–512

    Google Scholar 

  • Rizk NP, Tang L, Adusumilli PS et al (2009) Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma. J Thorac Oncol 4:875–879

    PubMed  Google Scholar 

  • Roder JD, Busch R, Stein HJ et al (1994) Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81:410–413

    CAS  PubMed  Google Scholar 

  • Rohatgi P, Swisher SG, Correa AM et al (2005) Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104:2365–2372

    PubMed  Google Scholar 

  • Rösch T (1995) Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 5:537–547

    PubMed  Google Scholar 

  • Rudolph RE, Vaughan TL, Storer BE et al (2000) Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 132:612–620

    CAS  PubMed  Google Scholar 

  • Rugge M, Bovo D, Busatto G et al (1997) p53 Alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev 6:171–176

    CAS  PubMed  Google Scholar 

  • Ruhstaller T, Widmer L, Schuller JC et al (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol 20:1522–1528

    CAS  PubMed  Google Scholar 

  • Sarkaria IS, Rizk NP, Bains MS et al (2009) Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg 249:764–767

    PubMed  Google Scholar 

  • Schneider PM, Baldus SE, Metzger R et al (2005) Histomorphologic tumor regression and lymph node metastases determeine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. Implications for response classification. Ann Surg 242:684–692

    PubMed  Google Scholar 

  • Schreiber D, Rineer J, Vongtama D et al (2010) Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5(2):244–250

    PubMed  Google Scholar 

  • Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459

    CAS  PubMed  Google Scholar 

  • Siewert JR, Stein HJ, Feith M et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234:360–367

    CAS  PubMed  Google Scholar 

  • Sobin LH, Gospodarowicz Mk, Wittekind C (eds) (2009) TNM classification of malignant tumours, 7th edn. Wiley VCH, Weinheim

    Google Scholar 

  • Spechler S (1994) Barrett’s esophagus. Semin Oncol 21:431–437

    CAS  PubMed  Google Scholar 

  • Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317

    PubMed  Google Scholar 

  • Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851–856

    CAS  PubMed  Google Scholar 

  • Stein HJ, Bartels H, Siewert JR (2001) Esophageal cancer: indications for two-stage procedures. Chirurg 72:881–886

    CAS  PubMed  Google Scholar 

  • Stein HJ, Feith M, Bruecher BL et al (2005) Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 242:566–573

    PubMed  Google Scholar 

  • Stein HJ, Hutter J, Feith M et al (2007) Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin Thorac Cardiovasc Surg 19:72–78

    PubMed  Google Scholar 

  • Steyerberg EW, Neville BA, Koppert LB et al (2006) Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 24:4277–4284

    PubMed  Google Scholar 

  • Stippel DL, Taylan C, Schroder W et al (2005) Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Dis Esophagus 18:267–273

    CAS  PubMed  Google Scholar 

  • Swisher SG, Maish M, Erasmus JJ et al (2004) Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78:1152–1157

    PubMed  Google Scholar 

  • Swisher SG, Hofstetter W, Wu TT et al (2005) Proposed revision of the esophageal cancer staging system to accommodate pathologic response following preoperative chemoradiation (CRT). Ann Surg 241:810–820

    PubMed  Google Scholar 

  • Takeuchi H, Fujii H, Ando N et al (2009) Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 249:757–763

    PubMed  Google Scholar 

  • Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092

    CAS  PubMed  Google Scholar 

  • Thomas T, Abrams KR, De Caestecker JS et al (2007) Meta analysis: cancer risk in Barrett’s oesophagus. Aliment Pharmacol Ther 26:1465–1477

    CAS  PubMed  Google Scholar 

  • Thompson JJ, Zinsser KR, Enterline HT (1983) Barrett’s metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 14:42–61

    CAS  PubMed  Google Scholar 

  • Tischoff I, Tannapfel A (2008) Barrett’s esophagus: can biomarkers predict progression to malignancy? Expert Rev Gastroenterol Hepatol 2:653–663

    CAS  PubMed  Google Scholar 

  • Turner JR, Shen LH, Crum CP et al (1997) Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 28:174–178

    CAS  PubMed  Google Scholar 

  • Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313

    CAS  PubMed  Google Scholar 

  • Urschel JD, Vasan H (2003) A meta-analysis of randomised controlled trials that compared neoadjuvant chemoradiation and surgery alone for resectable esophageal cancer. Am J Surg 185:538–543

    PubMed  Google Scholar 

  • Urschel JD, Vasan H, Blewett CJ (2002) A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 183:274–279

    PubMed  Google Scholar 

  • Vallböhmer D, Hölscher AH, Dietlein M et al (2009) [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 250:888–894

    PubMed  Google Scholar 

  • van Westreenen HL, Westerterp M, Sloof GW et al (2007) Limited additional value of positron emission tomography in staging oesophageal cancer. Br J Surg 94:1515–1520

    PubMed  Google Scholar 

  • Vieth M, Ell C, Gossner L, May A et al (2004) Histological analysis of endoscopic resection specimens from 326 patients with Barrett’s esophagus and early neoplasia. Endoscopy 36:776–781

    CAS  PubMed  Google Scholar 

  • Walsh T, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467

    CAS  PubMed  Google Scholar 

  • Weber WA, Ott K, Becker K et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058–3065

    CAS  PubMed  Google Scholar 

  • Westerterp M, Koppert LB, Buskens CJ et al (2005) Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 446:497–504

    PubMed  Google Scholar 

  • Westerterp M, van Westreenen HL, Deutekom M et al (2008) Patients’ perception of diagnostic tests in the preoperative assessment of esophageal cancer. Patient Prefer Adherence 2:157–162

    PubMed  Google Scholar 

  • Wiech T, Nikolopoulos E, Weis R et al (2009) Genome-wide analysis of genetic alterations in Barrett’s adenocarcinoma using single nucleotide polymorphism arrays. Lab Invest 89:385–397

    CAS  PubMed  Google Scholar 

  • Wieder H, Brucher BL, Zimmermann F et al (2004) Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22:900–908

    CAS  PubMed  Google Scholar 

  • Wieder HA, Ott K, Lordick F et al (2007) Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Eur J Nucl Med 34:1925–1932

    Google Scholar 

  • Witzig R, Schönberger B, Fink U et al (2006) Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy 38:1122–1126

    CAS  PubMed  Google Scholar 

  • Yokoyama A, Omori T, Yokoyama T et al (2008) Risk of metachronous squamous cell carcinoma in the upper aerodigestive tract of Japanese alcoholic men with esophageal squamous cell carcinoma: a long-term endoscopic follow-up study. Cancer Sci 99:1164–1171

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Medical Department, Klinikum Braunschweig, Hannover Medical School, Celler Straße 38, 38104, Braunschweig, Germany

    Florian Lordick

  2. Department of Surgery and Centre of Integrated Oncology (CIO), University of Cologne, Cologne, Germany

    Arnulf Hölscher

Authors
  1. Florian Lordick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arnulf Hölscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Lordick .

Editor information

Editors and Affiliations

  1. Div. Medical Oncology, University of British Columbia, West 10th Avenue 600, Vancouver, V5Z 4E6, British Columbia, Canada

    Charles D. Blanke

  2. FB 19 Zentrum der Radiologie, Klinik f. Strahlentherapie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, Frankfurt, 60590, Germany

    Claus Rödel

  3. Evanston Northwestern Healthcare, Northwestern University, Ridge Ave. 2650, Evanston, 60201, Illinois, USA

    Mark S. Talamonti

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Lordick, F., Hölscher, A. (2011). Esophageal Cancer. In: Blanke, C., Rödel, C., Talamonti, M. (eds) Gastrointestinal Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13306-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13306-0_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13305-3

  • Online ISBN: 978-3-642-13306-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation